Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Obesity and risk of female reproductive conditions: A Mendelian randomisation study

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 11:11
  • Read more about Obesity and risk of female reproductive conditions: A Mendelian randomisation study

Using phenotype risk scores to enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 11:09
  • Read more about Using phenotype risk scores to enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder

The major genetic risk factor for severe COVID-19 is associated with protection against HIV

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 11:07
  • Read more about The major genetic risk factor for severe COVID-19 is associated with protection against HIV

A genome-wide meta-analysis identifies 50 genetic loci associated with carpal tunnel syndrome

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 11:00
  • Read more about A genome-wide meta-analysis identifies 50 genetic loci associated with carpal tunnel syndrome

Fasting Insulin and Risk of Overall and 14 Site-Specific Cancers: Evidence From Genetic Data

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 10:58
  • Read more about Fasting Insulin and Risk of Overall and 14 Site-Specific Cancers: Evidence From Genetic Data

Causal Association of Type 2 Diabetes Mellitus and Glycemic Traits With Cardiovascular Diseases and Lipid Traits: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Thu, 09/29/2022 - 10:40
  • Read more about Causal Association of Type 2 Diabetes Mellitus and Glycemic Traits With Cardiovascular Diseases and Lipid Traits: A Mendelian Randomization Study

Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:35
  • Read more about Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study

Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:32
  • Read more about Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management

Childhood body size directly increases type 1 diabetes risk based on a lifecourse Mendelian randomization approach

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:30
  • Read more about Childhood body size directly increases type 1 diabetes risk based on a lifecourse Mendelian randomization approach

Genetics of smoking and risk of clonal hematopoiesis

Submitted by Frida Mäkelä on Fri, 09/23/2022 - 15:29
  • Read more about Genetics of smoking and risk of clonal hematopoiesis

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 489
  • Page 490
  • Page 491
  • Page 492
  • Current page 493
  • Page 494
  • Page 495
  • Page 496
  • Page 497
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement